IHC 8 Markers Therapy Resistance | Lahalak Platform
Analyzing 8 cellular pathways the tumor may use to evade treatment, enabling physicians to break the resistance cycle and restore treatment effectiveness or switch strategies.
Scientific name: Immunohistochemistry (IHC) Interpretation and Consultation (8 Markers)
A highly advanced analytical consultation package focusing on therapy resistance mechanisms. It relies on the systematic analysis of eight immunohistochemical (IHC) markers selected to cover diverse biological pathways associated with resistance: 1) DNA repair and genomic instability, 2) apoptosis, 3) growth and compensatory signaling, 4) drug tran...
Included Services
- In-depth analysis of eight immunological markers focused on treatment resistance mechanisms.
- Analytical comparison (if possible) with a previous baseline sample to understand biological evolution.
- Consult with a team specializing in resistance to cancer treatments to determine the prevailing mechanism and ways to overcome it.
- Issuing a "Report on the Analysis of Resistance Mechanisms and Appropriate Treatment Recommendations" with an explanation of the mechanism and a map of the pathways.
- Personal support services from Halak.
Medical Service Information
Conditions & Notices
- Accurate treatment information: It is necessary to know the type of treatment against which resistance has developed, and the duration of the initial response.
- Provide a sample of "resistance time": It is strongly preferable that the sample being examined be taken after the development of resistance and not before.
- Request for comparison: If the doctor wishes to compare with an archived specimen, it should be provided or its location indicated.
- No need for new samples or fasting.
- Expected duration: 14 to 28 working days for in-depth analysis and integration among experts.